Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 4, 2026
Intranasal Administration of Isoeugenol Improves Memory Deficits in APP/PS1 Old Mice-A Role Beyond Nrf2 Activation?Ana Silva, Sónia Silva, Jéssica Macedo, et al.Frontiers in Neuroscience|April 18, 2022
Feasibility and Long-Term Compliance to Continuous Positive Airway Pressure Treatment in Adults With Down Syndrome, a Genetic Form of Alzheimer's DiseaseSandra Giménez, Ariadna Farre, Fátima Morente, et al.Scientific Reports|March 28, 2020
Improving the drug-likeness of inspiring natural products - evaluation of the antiparasitic activity against Trypanosoma cruzi through semi-synthetic and simplified analogues of licarin AThiago R Morais, Geanne A Alves Conserva, Marina T Varela, et al.Oxidative Medicine and Cellular Longevity|March 23, 2026
Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory DisordersAna Silva, Sónia Silva, Beatriz Rodrigues, et al.Oxidative Medicine and Cellular Longevity|January 7, 2026
Targeting NRF2 With Isoeugenol: A Promising Small Molecule for Neurodegenerative, Metabolic, and Chronic Inflammatory DisordersAna Silva, Sónia Silva, Beatriz Rodrigues, et al.Antimicrobial Agents and Chemotherapy|October 9, 2024
Synthesis of a dehydrodieugenol B derivative as a lead compound for visceral leishmaniasis-mechanism of action and in vivo pharmacokinetic studiesMaiara Amaral, Maiara M Romanelli, Hannah Asiki, et al.Cureus|June 18, 2026
Subsequent Treatments After Progression on Cyclin-Dependent Kinase 4/6 Inhibitors: A Review of the Evidence and a Real-World Data Perspective From Portuguese HospitalsRita Freitas, Tiago Barroso, Sofia Braga, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|October 25, 2018
Prevalence of Sleep Disorders in Adults With Down Syndrome: A Comparative Study of Self-Reported, Actigraphic, and Polysomnographic FindingsSandra Giménez, Laura Videla, Sergio Romero, et al.Breast (Edinburgh, Scotland)|June 17, 2026
De-escalated chemotherapy and endocrine therapy outcomes in young women with stage I HR+/HER2+ breast cancer: An international real-world studyTal Sella, Frederieke van Duijnhoven, Hans Wildiers, et al.Breast (Edinburgh, Scotland)|December 12, 2025
Adjuvant ovarian function suppression and aromatase inhibitors in premenopausal patients with hormone receptor and HER2 positive breast cancer, by timing of chemotherapy and trastuzumab and response to neoadjuvant therapyAyelet Shai, Hans Wildiers, Claudio Venieri, et al.Pageof 15